Frederic Reu

Frederic Reu has a diverse work experience in the field of clinical development and oncology. Frederic is currently serving as the VP of Early Clinical Development at Deciphera Pharmaceuticals since September 2021. Prior to this, they held the position of Associate Professor at the USF Morsani College of Medicine from September 2020 to August 2021. Frederic also worked as an Associate Member at the H. Lee Moffitt Cancer Center and Research Institute from July 2020 to August 2021, where they focused on plasma cell disorder drug development and patient care, as well as educating medical students, residents, and fellows. Before that, they held various roles at Bristol Myers Squibb, including Senior Director of Early Clinical Development, Oncology, and Senior Early Clinical Lead, Oncology. Frederic also worked at the Cleveland Clinic as an Attending Physician in the Multiple Myeloma Program from September 2008 to May 2017, where they contributed to plasma cell disorder drug discovery, drug development, patient care, and medical education. In addition, they worked as a Physician in Hematologic Oncology at the University of Heidelberg from September 2006 to August 2008. Overall, Frederic Reu has extensive experience in clinical development, oncology, and medical education.

Frederic Reu has a Doctor of Medicine (MD) degree from the Medical School, University of Tübingen, which they obtained from 1990 to 1998. Frederic also completed an Internal Medicine Residency Program and a Medical Oncology fellowship in ABMI Research Track at Cleveland Clinic from 2000 to 2006. Frederic is a certified Internist and Medical Oncologist through the Cleveland Clinic Alumni Association. Frederic Reu also has expertise in Internal Medicine and Medical Oncology from the field of study they pursued at the Cleveland Clinic Alumni Association.